January 2016 - For the development of the DermalDose system and his contribution to the clinic, much research is necessary. The European Union supports this development through the European Regional Development Fund (ERDF). 

The aim of the ERDF is to support small and medium-sized enterprises, which are focused on one of the key priority areas: high tech systems and materials, health, agri-food and the low-carbon economy. The DermalDose system is a high tech system used for application in the health sector. The project meets the requirements for sustainable development as described by the European Union. Along with the funding of the ERDF, it is possible to perform the study designs as described in the status update of December 2016 in collaboration with Intravacc, the Institute for Translational Vaccinology and Leiden University.